Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics-Reference-Cited by-同舟云学术

Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics

Published:2006 Issue:12 Volume:119 Page:2784-2794
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Chen Zehan,Xiao Zhan,Gu Wen-zhen,Xue John,Bui Mai H.,Kovar Peter,Li Gaoquan,Wang Gary,Tao Zhi-Fu,Tong Yunsong,Lin Nan-Horng,Sham Hing L.,Wang Jean Y. J.,Sowin Thomas J.,Rosenberg Saul H.,Zhang Haiying

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference20 articles.

1. Cell-cycle checkpoint kinases: checking in on the cell cycle

2. The DNA damage response: putting checkpoints in perspective

3. Coordination of Repair, Checkpoint, and Cell Death Responses to DNA Damage

4. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Double‐strand DNA break repair: molecular mechanisms and therapeutic targets;MedComm;2023-10

2. Innate immune response restarts adaptive immune response in tumors;Frontiers in Immunology;2023-09-14

3. Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside;Biomedicine & Pharmacotherapy;2023-02

4. Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer;Cancers;2022-10-05

5. Enhancing anti-tumour innate immunity by targeting the DNA damage response and pattern recognition receptors in combination with radiotherapy;Frontiers in Oncology;2022-08-29